Christopher Fletcher
- Molecular Biology
- Cancer Research top 5%
- Pharmacology top 10%
- Oncology
- Genetics
- Co-authors
- Samuel SingerPasha SarrafRonald M. EvansPeter TontonozBruce M. SpiegelmanMing ZhangElisabetta Mueller
- Topics
- Peroxisome Proliferator-Activated Receptors (1 paper)Cancer, Lipids, and Metabolism (1 paper)Metabolism, Diabetes, and Cancer (1 paper)
- Partner nations
- United KingdomUnited States
In The Last Decade
Christopher Fletcher
4 papers receiving 734 citations
Hit Papers
Peers
Comparison fields: 5 of 64
- Molecular Biology 656
- Cancer Research 349
- Pharmacology 167
- Oncology 123
- Genetics 77
Countries citing papers authored by Christopher Fletcher
This map shows the geographic impact of Christopher Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Fletcher more than expected).
Fields of papers citing papers by Christopher Fletcher
This network shows the impact of papers produced by Christopher Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Fletcher. The network helps show where Christopher Fletcher may publish in the future.
Co-authorship network of co-authors of Christopher Fletcher
This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Fletcher. A scholar is included among the top collaborators of Christopher Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Fletcher. Christopher Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | Terminal Differentiation of Human Breast Cancer through PPARγbreakdown → | 739 |
| 3 | 2 | |
| 4 | 4 |
About Christopher Fletcher
Christopher Fletcher is a scholar working on Cancer Research, Molecular Biology and Infectious Diseases, having authored 4 papers that have together received 746 indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (1 paper), Cancer, Lipids, and Metabolism (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Cancer Research (349 citations), Pharmacology (167 citations) and Molecular Biology (656 citations). Christopher Fletcher has collaborated with scholars based in United Kingdom and United States. Frequent co-authors include Samuel Singer, Pasha Sarraf, Ronald M. Evans, Peter Tontonoz, Bruce M. Spiegelman, Ming Zhang and Elisabetta Mueller. Their work appears in journals such as Molecular Cell, The American Journal of Surgical Pathology and Human Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.